The 2025 Annual Meeting of the American Urological Association (AUA) is April 26-29 in Las Vegas, Nevada at The Venetian Convention & Expo Center.

Thomas Chi, M.D., MBA, professor and chair of the UAB Department of Urology, has been named named Anton J. Bueschen, M.D., Endowed Chair of Urologic Surgery and Research.

Obesity does not only put individuals at risk for heart disease and diabetes—it's also a leading cause of kidney stone disease.

Tanecia Mitchell, Ph.D., associate professor in the UAB Department of Urology, has been awarded the Division for Translational and Clinical Pharmacology Early Career Award by the American Society for Pharmacology and Experimental Therapeutics (ASPET). This prestigious award recognizes early-career scientists for their outstanding contributions to translational and clinical pharmacology research.

The UAB Department of Urology, in collaboration with the Mike Slive Foundation, provided free PSA blood testing to more than 65 men during the Auburn University Men’s Basketball “AUTLIVE” cancer game vs. The University of Tennessee on Jan.

Thomas Chi, M.D., MBA, joined the UAB Department of Urology as professor and chair in January 2025. Chi reflects on his first month in his new role and what he looks forward to as he helps shape the future of UAB Urology.

Soroush Rais-Bahrami, M.D., MBA, FACS, has been appointed the William H. Boyce Chair in Urology at Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist, effective June 1, 2025. 

UAB Medicine’s Leadership Development Office welcomed 16 individuals in its 10th cohort of Institute for Leadership in January 2025. UAB Medicine Institute for Leadership is a flagship program of the Leadership Development Office, aimed at empowering leaders across UAB and the UAB Health System.

The UAB Department of Urology is proud to welcome our newest class of residents in the 2025 Match. This year is particularly exciting as it celebrates the approval of a fourth spot in the highly competitive, ACGME-accredited residency training program.

The UAB Department of Urology is thrilled to announce approval for a fourth spot in its competitive ACGME-accredited residency training program for the 2025 match process. This supplemental match will occur through the secondary matching process from Jan.

Marissa Keppley, MBA, was announced the new Executive Administrator for the UAB Department of Urology, effective Feb. 10, 2025.

Now one of three internationally, UAB has recently been named an OHF Care Center for excellence in research and clinical care for rare kidney stone disease.

Joseph Crivelli, M.D., assistant professor in the Department of Urology, was recently named a recipient of the Rising Stars in Urology Research Award from the American Urological Association.

Identifying the early signs of kidney stone disease is crucial for preventing complications and managing symptoms.

UAB has been named a Care Center by the Oxalosis & Hyperoxaluria Foundation (OHF), making it one of three designated OHF Care Centers in the world. The designation marks UAB’s recognition as an international research hub and multidisciplinary clinical site focusing on primary hyperoxaluria and other rare kidney stone diseases.

Kidney stones can quietly form in the urinary tract, often without any immediate signs or symptoms. These solid crystals develop when certain substances in the urine combine, and the type of stone that forms depends on the specific composition of the urine.

Each November, the Department of Urology is proud to partner with the O’Neal Comprehensive Cancer Center and UAB Medicine to raise awareness for and promote education surrounding health issues like prostate and testicular cancer.

Join the UAB “Stubble To Support Men’s Health” campaign and make a difference in the fight against prostate cancer by growing facial hair in support of the cause.

UAB helps meet the needs of adults with spina bifida by providing care as one of the only adult spina bifida clinics in the Southeast.

Nine providers in the Department of Urology were recently recognized by the UAB Office of Patient Experience and Engagement for the exceptional care they delivered to patients during FY24. These providers achieved a 95 percent or higher top box rating (n ≥ 30) in care satisfaction based on patient feedback in Medallia.

Sunil Sudarshan, M.D., a professor in the Department of Urology, has been recognized as the latest winner of the Heersink School of Medicine’s Featured Discovery. This accolade honors and celebrates the significant research contributions made by Heersink’s faculty members.

For 11 consecutive years, U.S. News has named UAB Hospital the best hospital in Alabama, with several specialties and procedures ranked among the best.

After a national search, Thomas Chi, M.D., MBA, has been appointed Chair of the Department of Urology, effective Jan. 1, 2025.

Twenty exceptional faculty members were honored with the 2024 Dean’s Excellence Awards for their outstanding contributions across service, teaching, research, diversity enhancement, and mentorship within the School of Medicine.

The spring 2024 Endowed Chairs and Professorships Reception honored the distinguished faculty members of the Heersink School of Medicine for their outstanding impact on contemporary medicine and medical education. Anupam Agarwal, M.D., the dean of the Heersink School of Medicine, extended a warm welcome to the honorees, their families, and other leaders from the school.

The program seeks to support and foster multidisciplinary collaborations, especially between UAB clinicians and basic and physician scientists.

Vivek Lal, M.D., associate professor in the Department of Pediatrics at UAB Heersink School of Medicine and the founder of both ResBiotic Nutrition and Alveolus Bio, was given the 2023 Award for Excellence in Entrepreneurship.

In just the five years since UAB completed 10,000 robotic surgeries, surgeons across 15 disciplines have now collectively exceeded 20,000 robotic surgeries, setting a record for the hospital.

The researchers found that ARID1A-deficient bladder cancers are sensitive to combination therapies with the EZH2 inhibitor and inhibitors of PI3K, in a synergistic manner.

Patients at UAB now have access to state-of-the-art robotic surgery technology.